Skip to main content
. Author manuscript; available in PMC: 2008 Jan 14.
Published in final edited form as: Semin Oncol. 2007 Dec;34(6):524–531. doi: 10.1053/j.seminoncol.2007.09.002

Figure 1.

Figure 1

Persistence of tumor reactive lymphocytes after TIL transfer is evident by FACS analysis of dominant T cell receptor V beta usage (Patients 10, 16 and 21) or tetramer staining (Patient 28). Reprinted from Dudley et al. 2005 (Reference 23).